Accelero now on Twitter - #AcceleroBerlin
Accelero is twittering! Please follow us on #AcceleroBerlin. Enjoy!
Accelero is twittering! Please follow us on #AcceleroBerlin. Enjoy!
Berlin Cures GmbH is a clinical stage pharmaceutical company developing a short DNA aptamer BC 007 for the treatment of pathogenic autoantibodies against G-protein coupled receptors.
One of Berlin´s health authorities (Gesundheitsamt Treptow-Köpenick) has signed a contract for Accelero´s SARS-CoV-2 RT-PCR testing capabilities. The Berlin Senate Administration for Health asked Accelero to purchase swaps in bulk.
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.
The Nordic Life Science Days event is well known as the largest biotech conference in Scandinavia. This year the event was organized in Malmö/København on 10-12 September 2019. Accelero for the first time participated as an exhibitor - and drew attention with it´s own booth.
Accelero´s GLP compliant bioanalytical services have recently been published in Cytotherapy 21 (2019): 546-560.
Get the brand new ACCELERO hoodie - the first product from our emerging new accessory collection!
This product is part of a limited edition and is only available for a short time.
If you are client of our GLP test facility, get your own hoodie for free!
The BioVaria 2019 event is one of Germany´s leading showcasing events for commercially attractive licencing opportunities and innovative startups from across Europe. The event has been organized by Ascenion GmbH, one of Germany´s leading technology transfer agencies, at the Sofitel Munich Bayerpost Hotel from 08-09 May 2019.
Accelero will participate in the 2nd National ATMP Conference organized by the Center for Advanced Medical Products (CAMP) funded by VINNOVA, the Swedish Governmental Agency for Innovation Systems). The event will take place at the AstraZeneca campus south of Göteborg on Thursday 04-APR-2019.
Accelero feels constrained to assure highest quality for our regulatory studies. Team members will participate in the following annual congresses of quality assurance associations: 24. Annual Congress of the German Quality Management Association - 27 March 2019 Berlin 35. Annual Congress of the German Society for Pharmaceutical Medicine - 28 March 2019 Berlin.
Accelero is invited to participate in the Scientific Meeting "British German Alliance for Advanced Therapies" taking place in the British Embassy in Berlin on 26 March 2019.
The test facility manager was invited to hold a GLP round table seminar at one of Accelero´s clients based in Europe about the organization and management of (international) multi-site studies in compliance to GLP.
A brief anecdote about the inconvenient import procedure for non-human primate specimen collected from non-European origins and covered by CITES regulations.
The company is pleased to open the registration for new Good Laboratory Practice (GLP) seminars in 2019: Basic courses as well as a summer seminar on computerized systems are available!
Accelero is proud to announce that the test facility successfully passed a GLP inspection conducted on 15th and 16th of November 2018 by the competent state authority in Berlin, Germany.
Accelero is now allowed to process potentially infectious biological agents of risk group 3, which are normally not transmitted by air.
Meet Accelero team members at the 23rd International Meeting of the German Quality Management Association on 20-21 September 2018 in Bonn, Germany.
The company presented at the BIONNALE 2018 in Berlin - the largest biotech event in Germany´s capital region!
Accelero extends multiplex immunoassay capabilities - Luminex - LEGENDplex - FirePlex !
After eight years of serving the biotechnology business with bioanalytical services on human therapeutics, Accelero now is very pleased to support the regulatory development of an ATMP for veterinary pharmacology.
Accelero Bioanalytics GmbH
Part of the CCR Group B.V.
Volmerstrasse 9A
12489 Berlin
GERMANY
+49 30 610 910 300 (Office) | |
service(at)accelero-bioanalytics.com |